Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Gu茅rin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global TB Vaccines market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for TB Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for TB Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for TB Vaccines is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key manufacturers of TB Vaccines include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc. In 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes:
This report presents an overview of global market for TB Vaccines, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of TB Vaccines, also provides the sales of main regions and countries. Highlights of the upcoming market potential for TB Vaccines, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the TB Vaccines sales, revenue, market share and industry ranking of main manufacturers, data from 2018 to 2023. Identification of the major stakeholders in the global TB Vaccines market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2018 to 2029. Evaluation and forecast the market size for TB Vaccines sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc.
By Company
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
Segment by Application
Hospitals
Private Clinics
Research Institutes
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of TB Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: US & Canada (US & Canada) by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: China by type, by application sales and revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, sales and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TB Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Study Coverage
1.1 TB Vaccines Product Introduction
1.2 麻豆原创 by Type
1.2.1 Global TB Vaccines 麻豆原创 Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Immunotherapeutic Vaccines
1.2.3 Booster Vaccines
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global TB Vaccines 麻豆原创 Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Private Clinics
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global TB Vaccines Sales Estimates and Forecasts 2018-2029
2.2 Global TB Vaccines Revenue by Region
2.2.1 Global TB Vaccines Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global TB Vaccines Revenue by Region (2018-2023)
2.2.3 Global TB Vaccines Revenue by Region (2024-2029)
2.2.4 Global TB Vaccines Revenue 麻豆原创 Share by Region (2018-2029)
2.3 Global TB Vaccines Sales Estimates and Forecasts 2018-2029
2.4 Global TB Vaccines Sales by Region
2.4.1 Global TB Vaccines Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global TB Vaccines Sales by Region (2018-2023)
2.4.3 Global TB Vaccines Sales by Region (2024-2029)
2.4.4 Global TB Vaccines Sales 麻豆原创 Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global TB Vaccines Sales by Manufacturers
3.1.1 Global TB Vaccines Sales by Manufacturers (2018-2023)
3.1.2 Global TB Vaccines Sales 麻豆原创 Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of TB Vaccines in 2022
3.2 Global TB Vaccines Revenue by Manufacturers
3.2.1 Global TB Vaccines Revenue by Manufacturers (2018-2023)
3.2.2 Global TB Vaccines Revenue 麻豆原创 Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by TB Vaccines Revenue in 2022
3.3 Global Key Players of TB Vaccines, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global TB Vaccines Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers 麻豆原创 Concentration Ratio (CR5 and HHI)
3.5.2 Global TB Vaccines 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of TB Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of TB Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of TB Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 麻豆原创 Size by Type
4.1 Global TB Vaccines Sales by Type
4.1.1 Global TB Vaccines Historical Sales by Type (2018-2023)
4.1.2 Global TB Vaccines Forecasted Sales by Type (2024-2029)
4.1.3 Global TB Vaccines Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global TB Vaccines Revenue by Type
4.2.1 Global TB Vaccines Historical Revenue by Type (2018-2023)
4.2.2 Global TB Vaccines Forecasted Revenue by Type (2024-2029)
4.2.3 Global TB Vaccines Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global TB Vaccines Price by Type
4.3.1 Global TB Vaccines Price by Type (2018-2023)
4.3.2 Global TB Vaccines Price Forecast by Type (2024-2029)
5 麻豆原创 Size by Application
5.1 Global TB Vaccines Sales by Application
5.1.1 Global TB Vaccines Historical Sales by Application (2018-2023)
5.1.2 Global TB Vaccines Forecasted Sales by Application (2024-2029)
5.1.3 Global TB Vaccines Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global TB Vaccines Revenue by Application
5.2.1 Global TB Vaccines Historical Revenue by Application (2018-2023)
5.2.2 Global TB Vaccines Forecasted Revenue by Application (2024-2029)
5.2.3 Global TB Vaccines Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global TB Vaccines Price by Application
5.3.1 Global TB Vaccines Price by Application (2018-2023)
5.3.2 Global TB Vaccines Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada TB Vaccines 麻豆原创 Size by Type
6.1.1 US & Canada TB Vaccines Sales by Type (2018-2029)
6.1.2 US & Canada TB Vaccines Revenue by Type (2018-2029)
6.2 US & Canada TB Vaccines 麻豆原创 Size by Application
6.2.1 US & Canada TB Vaccines Sales by Application (2018-2029)
6.2.2 US & Canada TB Vaccines Revenue by Application (2018-2029)
6.3 US & Canada TB Vaccines 麻豆原创 Size by Country
6.3.1 US & Canada TB Vaccines Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada TB Vaccines Sales by Country (2018-2029)
6.3.3 US & Canada TB Vaccines Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe TB Vaccines 麻豆原创 Size by Type
7.1.1 Europe TB Vaccines Sales by Type (2018-2029)
7.1.2 Europe TB Vaccines Revenue by Type (2018-2029)
7.2 Europe TB Vaccines 麻豆原创 Size by Application
7.2.1 Europe TB Vaccines Sales by Application (2018-2029)
7.2.2 Europe TB Vaccines Revenue by Application (2018-2029)
7.3 Europe TB Vaccines 麻豆原创 Size by Country
7.3.1 Europe TB Vaccines Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe TB Vaccines Sales by Country (2018-2029)
7.3.3 Europe TB Vaccines Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China TB Vaccines 麻豆原创 Size
8.1.1 China TB Vaccines Sales (2018-2029)
8.1.2 China TB Vaccines Revenue (2018-2029)
8.2 China TB Vaccines 麻豆原创 Size by Application
8.2.1 China TB Vaccines Sales by Application (2018-2029)
8.2.2 China TB Vaccines Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia TB Vaccines 麻豆原创 Size by Type
9.1.1 Asia TB Vaccines Sales by Type (2018-2029)
9.1.2 Asia TB Vaccines Revenue by Type (2018-2029)
9.2 Asia TB Vaccines 麻豆原创 Size by Application
9.2.1 Asia TB Vaccines Sales by Application (2018-2029)
9.2.2 Asia TB Vaccines Revenue by Application (2018-2029)
9.3 Asia TB Vaccines Sales by Region
9.3.1 Asia TB Vaccines Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia TB Vaccines Revenue by Region (2018-2029)
9.3.3 Asia TB Vaccines Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America TB Vaccines 麻豆原创 Size by Type
10.1.1 Middle East, Africa and Latin America TB Vaccines Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America TB Vaccines Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America TB Vaccines 麻豆原创 Size by Application
10.2.1 Middle East, Africa and Latin America TB Vaccines Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America TB Vaccines Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America TB Vaccines Sales by Country
10.3.1 Middle East, Africa and Latin America TB Vaccines Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America TB Vaccines Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America TB Vaccines Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck & Co.,Inc
11.1.1 Merck & Co.,Inc Company Information
11.1.2 Merck & Co.,Inc Overview
11.1.3 Merck & Co.,Inc TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck & Co.,Inc TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck & Co.,Inc Recent Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Information
11.2.2 Sanofi Pasteur Overview
11.2.3 Sanofi Pasteur TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Sanofi Pasteur TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Pasteur Recent Developments
11.3 Japan BCG Laboratory
11.3.1 Japan BCG Laboratory Company Information
11.3.2 Japan BCG Laboratory Overview
11.3.3 Japan BCG Laboratory TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Japan BCG Laboratory TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Japan BCG Laboratory Recent Developments
11.4 China National Biotec Group
11.4.1 China National Biotec Group Company Information
11.4.2 China National Biotec Group Overview
11.4.3 China National Biotec Group TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 China National Biotec Group TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 China National Biotec Group Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Company Information
11.5.2 Serum Institute Overview
11.5.3 Serum Institute TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Serum Institute TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Serum Institute Recent Developments
11.6 India Pvt. Ltd
11.6.1 India Pvt. Ltd Company Information
11.6.2 India Pvt. Ltd Overview
11.6.3 India Pvt. Ltd TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 India Pvt. Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 India Pvt. Ltd Recent Developments
11.7 InterVax Ltd
11.7.1 InterVax Ltd Company Information
11.7.2 InterVax Ltd Overview
11.7.3 InterVax Ltd TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 InterVax Ltd TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 InterVax Ltd Recent Developments
11.8 GreenSignal
11.8.1 GreenSignal Company Information
11.8.2 GreenSignal Overview
11.8.3 GreenSignal TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 GreenSignal TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GreenSignal Recent Developments
11.9 Bio Pharma Limited
11.9.1 Bio Pharma Limited Company Information
11.9.2 Bio Pharma Limited Overview
11.9.3 Bio Pharma Limited TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Bio Pharma Limited TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Bio Pharma Limited Recent Developments
11.10 Statens Serum Institut
11.10.1 Statens Serum Institut Company Information
11.10.2 Statens Serum Institut Overview
11.10.3 Statens Serum Institut TB Vaccines Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Statens Serum Institut TB Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Statens Serum Institut Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 TB Vaccines Industry Chain Analysis
12.2 TB Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 TB Vaccines Production Mode & Process
12.4 TB Vaccines Sales and 麻豆原创ing
12.4.1 TB Vaccines Sales Channels
12.4.2 TB Vaccines Distributors
12.5 TB Vaccines Customers
13 麻豆原创 Dynamics
13.1 TB Vaccines Industry Trends
13.2 TB Vaccines 麻豆原创 Drivers
13.3 TB Vaccines 麻豆原创 Challenges
13.4 TB Vaccines 麻豆原创 Restraints
14 Key Findings in The Global TB Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
听
听
*If Applicable.